Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: The Clopidogrel With Aspirin in High-Risk Patients With Acute Nondisabling Cerebrovascular Events II (CHANCE-2) trial showed that ticagrelor-aspirin combination therapy reduced the risk of stroke compared with a clopidogrel-aspirin combination among carriers of CYP2C19 loss-of-function (...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xuewei, Johnston, S. Claiborne, Wang, Anxin, Xu, Qin, Bath, Philip M., Pan, Yuesong, Li, Hao, Lin, Jinxi, Wang, Yilong, Zhao, Xingquan, Li, Zixiao, Jiang, Yong, Liu, Liping, Xu, Anding, Jing, Jing, Meng, Xia, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245195/
https://www.ncbi.nlm.nih.gov/pubmed/37279000
http://dx.doi.org/10.1001/jamanetworkopen.2023.17037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245195/
https://www.ncbi.nlm.nih.gov/pubmed/37279000
http://dx.doi.org/10.1001/jamanetworkopen.2023.17037

Ejemplares similares